WSJ News Exclusive | Elliott Takes Big Stake in Drugmaker Catalent

The activist is demanding changes in the contract drug manufacturers board.

FDA Approves First RSV Drug to Protect All Infants From Virus

While the virus often causes mild, cold-like symptoms, it is the leading cause of hospitalization of…

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

Companies developing weight-loss drugs have raised or signed deals worth more than $1.4 billion since about…

Eli Lilly to Acquire Obesity-Treatment Maker Versanis

Versanis shareholders could receive up to $1.925 billion in cash in the form of upfront payments…

Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer

The company says the studies played a key role in lawsuits over its Baby Powder and…

WSJ News Exclusive | Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

RoiEvent, launched by presidential candidate Vivek Ramaswamy, may seal a deal in the coming days.

WSJ News Exclusive | Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

RoiEvent, launched by presidential candidate Vivek Ramaswamy, may seal a deal in the coming days.

FDA Approves First Over-the-Counter Birth-Control Pill

The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly increasing access to contraception…

Illumina Fined More Than $400 Million in Europe for Closing Grail Deal Early

The European Union’s antitrust watchdog fined the company the maximum allowable amount for completing its acquisition…

Investor Group Takes Aim at Antibiotics, Demanding Changes From Fast-Food Companies

Concern over the rise of drug-resistant superbugs is spreading beyond hospital wards and health clinics to…